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Background: The main objective of the joint action MODE is the transfer of best-practices in the field of organ
donation and transplantation and the creation of positive synergies among participating European (EU) Member
States (MS) apt to support authorities in possible decision-making and policy contexts.
Methods: The consortium has chosen to foster the exchange of best-practice through a series of exchange visits
followed by the provision of a set of specialized trainings.
Each participating MS has presented its strengths and weaknesses through a questionnaire based on the Organ
Action Plan. Once the situation was clearer, countries with the strongest program organized and hosted the on-site
visits and each country had the opportunity to perform five exchange visits on five selected topics.
Specific courses for healthcare staff of organ coordinating and transplantation centres were organized. Based on
evaluation of the results of the on-site visits and training needs indicated by the partners, the chosen topics were:
• reporting on adverse events and reactions
• quality assurance programme of the donation process in Spain
• quality assurance of the transplantation process
Results and conclusions: The outcome is that within the EU, even among MS with well-developed services, the
organ donation and transplantation activity has substantial differences so that all participating countries would
benefit from investigating foreign donation and transplant systems. Collaboration at EU level can be beneficial for
all systems and the joint action MODE indicated that in some countries the sharing of expertise across the EU
Member States has already proved to be useful in starting a virtuous circle in organization and training that would
allow to increase organ donor rates and improve overall performance.Background
For many patients, organ transplantation represents the
only lifesaving treatment available, a successful therapy
for some categories of patients suffering from serious
organ failures. This treatment has a positive outcome on
the medium and long term for about 80% of the
patients. This therapeutic opportunity is however
precluded to a number of patients due to organ* Correspondence: paola.diciaccio@iss.it
1Centro Nazionale Trapianti, Istituto Superiore di Sanità, Rome, Italy
Full list of author information is available at the end of the article
© 2013 Ciaccio et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orshortage. In 2003 the European Commission performed
a survey [1] from which it emerged that 56,000 patients
were waiting for a suitable organ donor in the EU and
every day 12 people were dying while waiting for trans-
plantation. Based on data collected yearly by ONT [2]
(Organization Nacional des Transplantes) and published
under the aegis of the Council of Europe, this amount
totted up to about 47.700 waiting individuals in 2010.
On the other side, cadaveric donation rates are more or
less stagnant on an average, since average number of ca-
daveric donors per million of population was equal to
17.1 in 2008, 17.0 in 2009 and 16.9 in 2010, with greatLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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European Commission has therefore committed to iden-
tify the major policy challenges in the field of organ do-
nation and transplantation with priority toward (1)
ensuring the quality and safety of human organs, (2)
increasing organ availability and (3) enhancing the effi-
ciency and accessibility of transplantation systems in the
European Union. These three challenges are effectively
addressed by the “Directive on standards of quality and
safety of human organs intended for transplantation”
(2010/53/EU) [3] adopted by the EU Parliament on July
7 2010 and by Action Plan on Organ Donation and
Transplantation, aiming at strengthening cooperation
between Member States. The Directive provides for the
appointment of Competent Authorities in all Member
States, for authorization of procurement and transplant-
ation centres and activities, for traceability systems, as
well as for the reporting of serious adverse events and
reactions and EU MS should have implemented such
requirements in their legal systems by 27 August 2012.
As it is well indicated in the white paper issued in 2007
by the EU Commission “Together for Health: A strategic
approach for the EU: 2008-2013” [4], MS have the main
responsibility for health policy and provision of
healthcare to European citizens but there are areas
where MS cannot act alone effectively. Organ donation
and transplantation is a great example of application of
such strategy, that the whole transplant community
hopes will prove to be successful in the near future.
Methods
The Joint Action tool is the best methodological instru-
ment suited to enable participating MS to further con-
tribute to the process identified by the European
Commission, since a formal commitment is required by
Member States that delegate partners to perform the ac-
tion. The Joint Action “Mutual Organ Donation and
Transplantation Exchanges – MODE” is an 18-month
project co-funded by the European Commission under
the Public Health Program (DG Health and Consumer
Protection), Grant 20102101. It started on January 1st
2011 and ended on June 30th 2012. This joint action
was meant to contribute to the on-going EU policy
allowing transmission of best practices in the three
above-mentioned fields (quality and safety, organTable 1 Criteria for definition of best practices in the mutual
action MODE, 2011–2012
Quality and safety Overview of quality/safety national pr
to programmes for notification of adv
Organ donation Overview of national programmes for
rates
Efficiency and accessibility of
transplant systems
Analysis and comparison of existing ndonation, efficiency and accessibility of transplant
systems) identified by the EU 53/2010 Directive as prior-
ity sectors of action. Table 1 describes the major criteria
used for defining “best practices” in each of these fields.
The joint action Mode intended to complement MS
policies in the field of organ donation and transplant-
ation through cross-border cooperation. Such best-
practice know-how transfer has been implemented
through a series of actions starting with the identifica-
tion of interest sectors, followed by exchange visits with
a focus on identified items and specific training. The
expected outcome was that since even European Union
countries with well-developed services show significant
differences in organ donation and transplantation activ-
ity, all participating countries would have benefited from
investigating foreign donation and transplant systems in
place. Another positive expected effect was the creation
of positive synergies among participating MS apt to sup-
port authorities in possible decision-making and policy
contexts.Results and Discussion
In the organ donation and transplantation field each
country has its own history and practices, its own
organization, structure and conditions, and something to
offer its counterparts and some needs to be coped with.
The Joint Action MODE consortium, that has been
coordinated by Centro Nazionale Trapianti / Istituto
Superiore di Sanità – Italy, involved as associated
partners a good number of national organ donation and
transplant organizations from several EU MS, namely,
Országos Vérellátó Szolgálat – Hungary, Autoridiade
para os Serviçios de Sangue e de Transplantação –
Portugal, Organización Nacional de Trasplantes – Spain,
Koordinacni Stredisko Transplantaci – Czech Republic,
Slovenija Transplant – Slovenia, Pauls Stradins Clinical
University Hospital – Latvia, Lithuanian National Trans-
plantation Bureau Lithuania, Tartu University Hospital –
Estonia, Bulgarian Executive Agency for Transplantation
– Bulgaria and Mater Dei Hospital – Malta. The consor-
tium partnership was therefore a good representative
sample of MS from different EU areas and allowed to
gather a number of different approaches to the organ
donation and transplantation issue.organ donation and transplantation exchanges, EU joint
ogrammes and evaluation of programme results, with special attention
erse events and reactions
monitoring devastating brain injuries in ICUs and analysis of donation
ational programmes for evaluation of transplant outcomes
Table 2 Summary of on-site exchange visits
Hosting partner Organ action plan priority Main topic
ONT Spain (1) Increasing organ availability Quality improvement programs
KST Czech Rep. (2) Enhancing efficiency and availability of transplant systems Supporting and guiding organizational models
ASST Portugal (2) Enhancing efficiency and availability of transplant systems Supporting international exchange of organs for transplantations
ST Slovenia (2) Enhancing efficiency and availability of transplant systems Increasing deceased donation to their full potential
CNT Italy (3) Improving quality and safety of transplants Evaluation of post-transplantation results
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identify the field of action for the exchange visits, a
questionnaire based on the Organ Action Plan was
circulated among partners in order to allow each coun-
try to analyze and present its strengths and weaknesses.
In the same questionnaire a section was devoted to a
survey on training needs. The partner responsible for
such activity (KST from Czech Republic) worked out a
chart flow with answers that was discussed by the con-
sortium and a SWOT (Strenghts/Weaknesses/Oppor-
tunities/Threats) analysis was applied at national level,
so that replies to the questionnaire were processed in a
point diagram showing the score and level of intensity of
individual replies.
As outcome of this SWAT analysis and upon final de-
cision of the whole consortium, five topics and five
countries were singled out and onsite visits were
organized accordingly. Each country had the opportunity
to take part in each of such visits. Table 2 gives an over-
view of the topics of the visit and location, together with
reference to Organ Action Plan goal.Table 3 Content of the training for mutual organ donation an
2011–2012
Issue






The Quality Assurance Program of the donation Process in Spain:









Quality Assurance of the Transplantation Process Qualit
Analys
Organ
ExternAt the end of the five visits, each partner wrote a
memorandum explaining if the topic chosen could be
implemented in his country and how this could be done
while at the same time providing a description of barrier
which may hamper the implantation. As a result, in
October 2011, a final detailed report of such visits
describing their outcome was drawn up.
On the basis of onsite visit outcomes and identified
training needs, three topics were selected and training
courses were developed by the responsible partner, ONT
from Spain, in close collaboration with the whole con-
sortium. The topics were the “Reporting on adverse
events and reactions”, the “Quality assurance program of
the donation process” and the “Quality assurance of the
transplantation process”. The reporting of adverse events
and reaction was a completely new topic and had not
been covered by any specific exchange visit, but the
growing interest for this activity and its focus on impor-
tant aspects of the implementing Directive such as bio
vigilance and surveillance on substances of human origin
in Europe pushed the consortium to add specificd transplantation exchanges, EU joint action MODE,
Topic
mentals of risk management
iew. – Need for a safety system. The Italian approach
ization of bio vigilance system (by the Competent Authorities and
ure and responsibilities)
to support decisions: literature and Notify project
ted exercises of bio vigilance
al description of the Spanish “Quality Assurance programme of the
ion Process”
ternal evaluation phase: objectives, methodology, tools and database,
and usefulness
al work: quality indicators, results and analysis
ternal audit: key-points. Objectives, methodology, tools and database,
and usefulness
al work: the external audit report: Practical cases
y indicators for assessing organ transplant
is of outcomes
isation of registries and collaboration with internal registries
al audits of transplant centries
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were concentrated on quality indicators for dona-
tion processes and organization of registries and meth-
odologies for analysis of transplant outcomes. Training
courses included two phases, online face-to-face and
were mainly addressed to the staff from national
organizations or Competent Authorities that were dir-
ectly working in the field of organ donation and trans-
plantation. From March 1st to 31st, attendees were
enrolled and they were provided with educational mater-
ial. Next, they were assigned a user-id and password to
access a webplatform through which they took part into
an e-learning session from April 16th to 26th that
included tests and surveys and forum discussions. Even-
tually, from May 7 to 9th three face-to-face courses
(eight hours each) were held in Madrid at the Escuela
Nacional de Sanidad (National School of Health). Con-
tent finalization is shown in Table 3. The courses have
been certified by the MODE consortium.
Conclusions
From a general point of view the major action output
was the acquired knowledge of best-practice system and
also the awareness of the obstacles that hinder the full
transfer of such practices in donation and transplant
systems. Indeed, the fact that Directive implementation
date was set for end August 2012 and that a number of
countries are still discussing many details of such imple-
mentation did not allow us to make a full evaluation of
long-term effects of our efforts, above all in measureable
terms. During the last meeting held in Rome end June
2012, each partner was asked to deliver a presentation
on the concrete possibility of best practices transfer, and
on the state of the art of Directive implementation. They
also illustrated which topics of the training they had
found as most useful. That was the occasion for an open
discussion of the results obtained through the joint ac-
tion and on the obstacles mainly caused by the local pol-
itical situation, e.g. lack of resources.
One of the main results emerged during the final
meeting is that the importance of Authorities and policy
makers involvement in order to obtain the needed
resources and reach set goals. It is also worthwhile
mentioning that all partners stressed that investment of
resources and organizational efforts are more than ever
needed in order to achieve desired results in organ do-
nation and transplantation field, and unfortunately the
present economic situation in Europe does not foster
such approach. The main positive conclusion was no
doubt the general agreement on the usefulness of having
identified the fields where best practice transfer is most
needed and of having given the possibility to train
dedicated staff from Competent Authorities on such
topics: a first step forward and a correct way of investingthe resources allocated by the European Union to such
action.
For further information and follow-up of our project,
please visit the website “http://www.mode-ja.org/node/2”.
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